tradingkey.logo
搜索

Canton Strategic Holdings Ord Shs

CNTN
添加自选
1.710USD
-0.090-5.00%
收盘 11-13 16:00(美东)
136.25M总市值
亏损市盈率 TTM

关于 Canton Strategic Holdings Ord Shs 公司

Tharimmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutic candidates for inflammatory and immunologic conditions with unmet need. It has a transmucosal film product, TH104, is a Phase II ready clinical candidate and an oral biologic as well as two bispecific biologics in pre-clinical development. TH104 is a transmucosal buccal film embedded with the active compound nalmefene onto a thin film which adheres inside of the mouth on the cheek and biodegrades. TH104 is an ideal product candidate for multiple liver-related and other pruritogenic inflammatory conditions. It is also developing an early-stage pipeline of novel therapeutic candidates targeting validated high value immune-oncology targets including human epidermal growth factor receptor 2, human EGF receptor 3 and programmed cell death protein. The Company is developing antibodies, including bispecific antibodies, antibody drug conjugates, among others.

Canton Strategic Holdings Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Canton Strategic Holdings Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Mark Toomey
Mr. Mark Toomey
President
President
--
--
Mr. William Wiley
Mr. William Wiley
Independent Director
Independent Director
--
--
Mr. Sean P. Galvin
Mr. Sean P. Galvin
Independent Director
Independent Director
--
--
Ms. Pamela Lynn Carter
Ms. Pamela Lynn Carter
Independent Director
Independent Director
--
--
Mr. Rishi Nangalia
Mr. Rishi Nangalia
Independent Director
Independent Director
--
--
,
,
--
--
Mr. Clay Kahler
Mr. Clay Kahler
Independent Director
Independent Director
--
--
Mr. Mark Wendland
Mr. Mark Wendland
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Pamela Lynn Carter
Ms. Pamela Lynn Carter
Independent Director
Independent Director
--
--
Mr. Sean P. Galvin
Mr. Sean P. Galvin
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Mark Toomey
Mr. Mark Toomey
President
President
--
--
Mr. William Wiley
Mr. William Wiley
Independent Director
Independent Director
--
--
Mr. Sean P. Galvin
Mr. Sean P. Galvin
Independent Director
Independent Director
--
--
Ms. Pamela Lynn Carter
Ms. Pamela Lynn Carter
Independent Director
Independent Director
--
--
Mr. Rishi Nangalia
Mr. Rishi Nangalia
Independent Director
Independent Director
--
--
,
,
--
--

常见问题

Canton Strategic Holdings Ord Shs的前五大股东是谁?

Canton Strategic Holdings Ord Shs 的前五大股东如下: ,
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有